aTYR PHARMA INC financial data

Symbol
ATYR on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 05 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 603% % -0.67%
Return On Equity -100% % -17%
Return On Assets -74% % -18%
Operating Margin -40856% % -41%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 98,051,212 shares 10%
Common Stock, Shares, Outstanding 98,031,104 shares 17%
Entity Public Float $463,822,834 USD 299%
Common Stock, Value, Issued $98,000 USD 17%
Weighted Average Number of Shares Outstanding, Basic 92,985,359 shares 25%
Weighted Average Number of Shares Outstanding, Diluted 92,985,359 shares 25%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $190,000 USD -19%
Research and Development Expense $60,219,000 USD 11%
General and Administrative Expense $17,598,000 USD 28%
Operating Income (Loss) $77,627,000 USD -14%
Nonoperating Income (Expense) $3,504,000 USD -10%
Net Income (Loss) Attributable to Parent $74,118,000 USD -16%
Earnings Per Share, Basic -0.8 USD/shares 7%
Earnings Per Share, Diluted -0.8 USD/shares 7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $10,743,000 USD -2.8%
Assets, Current $80,237,000 USD -2.1%
Property, Plant and Equipment, Net $4,263,000 USD -12%
Operating Lease, Right-of-Use Asset $5,524,000 USD -5%
Other Assets, Noncurrent $148,000 USD 124%
Assets $93,003,000 USD -4%
Accounts Payable, Current $3,891,000 USD -10%
Employee-related Liabilities, Current $2,986,000 USD -3.5%
Accrued Liabilities, Current $9,791,000 USD 4.2%
Liabilities, Current $15,148,000 USD 1.2%
Operating Lease, Liability, Noncurrent $10,308,000 USD -7.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax $8,000 USD 80%
Retained Earnings (Accumulated Deficit) $606,164,000 USD -14%
Stockholders' Equity Attributable to Parent $67,480,000 USD -3.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $67,288,000 USD -3.6%
Liabilities and Equity $93,003,000 USD -4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $15,420,000 USD 31%
Net Cash Provided by (Used in) Financing Activities $18,628,000 USD 141%
Net Cash Provided by (Used in) Investing Activities $4,420,000 USD -226%
Common Stock, Shares Authorized 170,000,000 shares 0%
Common Stock, Shares, Issued 98,031,104 shares 17%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,212,000 USD 92%
Interest Paid, Excluding Capitalized Interest, Operating Activities $28,000 USD -26%
Deferred Tax Assets, Valuation Allowance $142,194,000 USD 15%
Deferred Tax Assets, Gross $143,354,000 USD 14%
Operating Lease, Liability $11,144,000 USD -6%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $74,086,000 USD -16%
Property, Plant and Equipment, Gross $9,091,000 USD -3.2%
Operating Lease, Liability, Current $836,000 USD 18%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,916,000 USD 7.6%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,780,000 USD 3.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.088 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5,637,000 USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,975,000 USD 3.1%
Deferred Tax Assets, Operating Loss Carryforwards $79,097,000 USD 15%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $42,811,000 USD 16%
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,035,000 USD 3%
Additional Paid in Capital $673,554,000 USD 12%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $167,000 USD -6.2%
Deferred Tax Assets, Net of Valuation Allowance $1,160,000 USD -5.2%
Share-based Payment Arrangement, Expense $4,997,000 USD 67%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%